SPIA
NVIV

Steward Partners Investment Advisory’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Steward Partners Investment Advisory’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200
Closed -$3K – 3417
2021
Q3 		$3K Hold
200
– – ﹤0.01% 2964
2021
Q2 		$4K Hold
200
– – ﹤0.01% 6727
2021
Q1 		$4.97K Buy
+200
New +$6K ﹤0.01% 3005
2018
Q4 		– Hold
0
– – – 2582
2018
Q3 		– Hold
0
– – – 2809
2018
Q2 		– Hold
0
– – – 2635
2018
Q1 		– Hold
0
– – – 2411
2017
Q4 		– Hold
0
– – – 2017
2017
Q3 		– Hold
0
– – – 1644
2017
Q2 		– Hold
0
– -$2K – 1761
2017
Q1 		– Hold
0
– – – 1352

Other funds holding NVIV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Steward Partners Investment Advisory's NVIV Position: Q4 2021 in Review

Steward Partners Investment Advisory sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q4 2021, closing a stake of 200 shares — an estimated $3K sold.

Steward Partners Investment Advisory first reported a position in NVIV in Q1 2021 and held it in 3 quarters. The position peaked at $4.97K in Q1 2021. 19 funds tracked by Wall St. Rank hold NVIV as of Q4 2021.

  • Steward Partners Investment Advisory reported no remaining InVivo Therapeutics Holdings Corp position as of Q4 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 200 InVivo Therapeutics Holdings Corp shares in Q4 2021, an estimated $3K.
  • Steward Partners Investment Advisory first reported a position in InVivo Therapeutics Holdings Corp in Q1 2021 and held it in 3 quarters.
  • Steward Partners Investment Advisory's InVivo Therapeutics Holdings Corp position peaked at $4.97K in Q1 2021.
  • 19 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q4 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2021, filed 8 Feb 2022.